IFNG and rheumatoid arthritis: In agreement, a recently published clinical study for 63 refractory RA patients showed that 1 × 106 IU of recombinant IFN-γ that injected intramuscularly increased the effectiveness of simultaneous delivered UC-MSCs (intravenous 1 × 106 MSCs/kg of body weight) by nearly 2-fold (168).